01 1AbbVie Corporation
02 2Allergan Inc.
03 2Gowling WLG (Canada) LLP
04 1Warner Chilcott Canada Co.
05 9Blank
Patent Expiration Date : 2018-07-17
Date Granted : 2001-08-21
Brand Name : ACTONEL
Patent Number : 2294595
Filing Date : 1998-07-17
Strength per Unit : 35 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-07-17
Date Granted : 2001-08-21
Patent Expiration Date : 2018-07-17
Date Granted : 2001-08-21
Brand Name : ACTONEL
Patent Number : 2294595
Filing Date : 1998-07-17
Strength per Unit : 75mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-07-17
Date Granted : 2001-08-21
Patent Expiration Date : 2025-11-23
Date Granted : 2009-10-13
Brand Name : ACTONEL DR
Patent Number : 2602188
Filing Date : 2005-11-23
Strength per Unit : 35 mg
Dosage Form : Delayed Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-11-23
Date Granted : 2009-10-13
Patent Expiration Date : 2018-07-17
Date Granted : 2001-08-21
Brand Name : ACTONEL DR
Patent Number : 2294595
Filing Date : 1998-07-17
Strength per Unit : 35 mg
Dosage Form : Delayed Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-07-17
Date Granted : 2001-08-21
Patent Expiration Date : 2023-05-02
Date Granted : 2014-01-07
Brand Name : ACTONEL
Patent Number : 2763775
Filing Date : 2003-05-02
Strength per Unit : 150 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2023-05-02
Date Granted : 2014-01-07
LOOKING FOR A SUPPLIER?
